Abstract
Oxygen derived free radicals are considered to play an important part in the development of inflammation. A whole blood chemiluminescence assay was used to study N-formyl-methionyl-leucyl-phenylalanine induced oxygen radical production in subjects with ankylosing spondylitis or previous yersinia arthritis. In luminol enhanced chemiluminescence, the subjects with previous yersinia arthritis showed significantly increased initial activation (at one minute), whereas the subjects with ankylosing spondylitis showed decreased responses at both the initial activation and at peak activation (at two to three minutes). This finding gives credence to the view that, in terms of oxygen radical production, the pathogenesis of yersinia arthritis is different from that of ankylosing spondylitis.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allen R. C. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol. 1986;133:449–493. doi: 10.1016/0076-6879(86)33085-4. [DOI] [PubMed] [Google Scholar]
- Bender J. G., Van Epps D. E. Analysis of the bimodal chemiluminescence pattern stimulated in human neutrophils by chemotactic factors. Infect Immun. 1983 Sep;41(3):1062–1070. doi: 10.1128/iai.41.3.1062-1070.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brewerton D. A. Joseph J. Bunim Memorial Lecture. HLA-B27 and the inheritance of susceptibility to rheumatic disease. Arthritis Rheum. 1976 Jul-Aug;19(4):656–668. doi: 10.1002/1529-0131(197607/08)19:4<656::aid-art1780190402>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
- Camisa C., Eisenstat B., Ragaz A., Weissmann G. The effects of retinoids on neutrophil functions in vitro. J Am Acad Dermatol. 1982 Apr;6(4 Pt 2 Suppl):620–629. doi: 10.1016/s0190-9622(82)70051-9. [DOI] [PubMed] [Google Scholar]
- Chen J. H., Kono D. H., Yong Z., Park M. S., Oldstone M. M., Yu D. T. A Yersinia pseudotuberculosis protein which cross-reacts with HLA-B27. J Immunol. 1987 Nov 1;139(9):3003–3011. [PubMed] [Google Scholar]
- Dahlgren C., Aniansson H., Magnusson K. E. Pattern of formylmethionyl-leucyl-phenylalanine-induced luminol- and lucigenin-dependent chemiluminescence in human neutrophils. Infect Immun. 1985 Jan;47(1):326–328. doi: 10.1128/iai.47.1.326-328.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ebringer A., Cox N. L., Abuljadayel I., Ghuloom M., Khalafpour S., Ptaszynska T., Shodjai-Moradi F., Wilson C. Klebsiella antibodies in ankylosing spondylitis and Proteus antibodies in rheumatoid arthritis. Br J Rheumatol. 1988;27 (Suppl 2):72–85. doi: 10.1093/rheumatology/xxvii.suppl_2.72. [DOI] [PubMed] [Google Scholar]
- Geczy A. F., McGuigan L. E., Sullivan J. S., Edmonds J. P. Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis. J Exp Med. 1986 Sep 1;164(3):932–937. doi: 10.1084/jem.164.3.932. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Granfors K., Jalkanen S., Lindberg A. A., Mäki-Ikola O., von Essen R., Lahesmaa-Rantala R., Isomäki H., Saario R., Arnold W. J., Toivanen A. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 1990 Mar 24;335(8691):685–688. doi: 10.1016/0140-6736(90)90804-e. [DOI] [PubMed] [Google Scholar]
- Granfors K., Jalkanen S., von Essen R., Lahesmaa-Rantala R., Isomäki O., Pekkola-Heino K., Merilahti-Palo R., Saario R., Isomäki H., Toivanen A. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med. 1989 Jan 26;320(4):216–221. doi: 10.1056/NEJM198901263200404. [DOI] [PubMed] [Google Scholar]
- Gyllenhammar H. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J Immunol Methods. 1987 Mar 12;97(2):209–213. doi: 10.1016/0022-1759(87)90461-3. [DOI] [PubMed] [Google Scholar]
- Hoogkamp-Korstanje J. A., de Koning J., Heesemann J. Persistence of Yersinia enterocolitica in man. Infection. 1988 Mar-Apr;16(2):81–85. doi: 10.1007/BF01644307. [DOI] [PubMed] [Google Scholar]
- Koivuranta-Vaara P., Leirisalo-Repo M., Repo H. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease. Ann Rheum Dis. 1987 Apr;46(4):307–313. doi: 10.1136/ard.46.4.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leirisalo-Repo M., Suoranta H. Ten-year follow-up study of patients with Yersinia arthritis. Arthritis Rheum. 1988 Apr;31(4):533–537. doi: 10.1002/art.1780310410. [DOI] [PubMed] [Google Scholar]
- Merry P., Winyard P. G., Morris C. J., Grootveld M., Blake D. R. Oxygen free radicals, inflammation, and synovitis: and synovitis: the current status. Ann Rheum Dis. 1989 Oct;48(10):864–870. doi: 10.1136/ard.48.10.864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller C., Russell A. S. The generation of superoxide anions by polymorphonuclear leucocytes from patients with ankylosing spondylitis in response to the stimulant f-met-leu-phe. Clin Exp Rheumatol. 1986 Apr-Jun;4(2):135–137. [PubMed] [Google Scholar]
- Repo H., Koivuranta-Vaara P., Leirisalo-Repo M., Lauharanta J., Osterman T., Vapaatalo H. Etretinate therapy and neutrophil function in a patient with reactive arthritis triggered by Salmonella infantis. Clin Exp Rheumatol. 1987 Oct-Dec;5(4):388–390. [PubMed] [Google Scholar]
- Repo H., Koivuranta-Vaara P., Leirisalo-Repo M. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations. Ann Rheum Dis. 1988 Jun;47(6):452–457. doi: 10.1136/ard.47.6.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Repo H., Leirisalo M., Koivuranta P., Osterman T., Kiistala U., Gahmberg C. G., Vapaatalo H., Tiilikainen A., Laitinen O. Neutrophil function and HLA-B27. Br J Rheumatol. 1983 Nov;22(4 Suppl 2):168–171. doi: 10.1093/rheumatology/xxii.suppl_2.168. [DOI] [PubMed] [Google Scholar]
- Ristola M. Increased oxygen radical production determined by whole blood chemiluminescence in patients with previous Yersinia arthritis. APMIS. 1990 Feb;98(2):125–130. doi: 10.1111/j.1699-0463.1990.tb01011.x. [DOI] [PubMed] [Google Scholar]
- Ristola M., Repo H. Luminol-enhanced chemiluminescence of whole blood. Statistical analysis, and comparison of the responses of different subjects. APMIS. 1989 Jun;97(6):503–512. [PubMed] [Google Scholar]
- Rosenbaum J. T. Why HLA-B27: an analysis based on two animal models. Ann Intern Med. 1981 Feb;94(2):261–263. doi: 10.7326/0003-4819-94-2-261. [DOI] [PubMed] [Google Scholar]
- Serrander R., Magnusson K. E., Kihlström E., Sundqvist T. Acute yersinia infections in man increase intestinal permeability for low-molecular weight polyethylene glycols (PEG 400). Scand J Infect Dis. 1986;18(5):409–413. doi: 10.3109/00365548609032356. [DOI] [PubMed] [Google Scholar]
- Sheldon P. Specific cell-mediated responses to bacterial antigens and clinical correlations in reactive arthritis, Reiter's syndrome and ankylosing spondylitis. Immunol Rev. 1985 Aug;86:5–25. doi: 10.1111/j.1600-065x.1985.tb01135.x. [DOI] [PubMed] [Google Scholar]
- Tertti R., Granfors K., Lahesmaa-Rantala R., Toivanen A. Serum opsonic capacity against Yersinia enterocolitica O:3 in yersiniosis patients with or without reactive arthritis. Clin Exp Immunol. 1989 May;76(2):227–232. [PMC free article] [PubMed] [Google Scholar]
- Toivanen A., Granfors K., Lahesmaa-Rantala R., Leino R., Ståhlberg T., Vuento R. Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects. Immunol Rev. 1985 Aug;86:47–70. doi: 10.1111/j.1600-065x.1985.tb01137.x. [DOI] [PubMed] [Google Scholar]
- Urman J. D., Zurier R. B., Rothfield N. F. Reiter's syndrome associated with champylobacter fetus infection. Ann Intern Med. 1977 Apr;86(4):444–445. doi: 10.7326/0003-4819-86-4-444. [DOI] [PubMed] [Google Scholar]
- el Abbouyi A., Paul J. L., Roch-Arveiller M., Moachon L., Dougados M., Giroud J. P., Amor B., Raichvarg D. Blood polymorphonuclear behavior in patients with ankylosing spondylitis. Clin Exp Rheumatol. 1988 Oct-Dec;6(4):401–403. [PubMed] [Google Scholar]